{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T06:24:15Z","timestamp":1778394255051,"version":"3.51.4"},"reference-count":130,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2012,1,24]],"date-time":"2012-01-24T00:00:00Z","timestamp":1327363200000},"content-version":"vor","delay-in-days":9632,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["accpjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacotherapy"],"published-print":{"date-parts":[[1985,9,10]]},"abstract":"<jats:p>Ceftazidime is an aminothiazolyl cephalosporin with potent activity against gram\u2010negative bacteria including multiresistant strains of <jats:italic>Pseudomonas aeruginosa<\/jats:italic>. It has limited activity against gram\u2010negative anaerobes, is less active against some gram\u2010positive cocci than other newer beta\u2010lactam compounds and is inactive against <jats:italic>Streptococcus faecalis<\/jats:italic> and methicillin\u2010resistant <jats:italic>Staphylococcus aureus<\/jats:italic>. Ceftazidime is stable against common plasmid and chromosomally mediated beta\u2010lactamase produced by <jats:italic>Enterobacteriaceae<\/jats:italic> and <jats:italic>Pseudomonas<\/jats:italic> sp. Its pharmacokinetic properties are similar to those of moxalactam and ceftizoxime, and it has a half\u2010life of 1.9 hours. Excretion is by glomerular filtration. It is not metabolized. Ceftazidime penetrates into most body tissue and fluids, including cerebrospinal fluid, and produces therapeutic levels against most of the pathogenic gram\u2010negative bacteria, including <jats:italic>P. aeruginosa<\/jats:italic>. Ceftazidime accumulates during renal failure, but is removed by hemodialysis and peritoneal dialysis. As a single agent it has been shown effectively to treat meningitis; urinary tract infections; gram\u2010negative pneumonia; bone, joint and skin infections; and obstetric and gynecologic infections due to susceptible organisms. When combined with an agent that is effective against gram\u2010positive organisms, it is also beneficial in the treatment of infections in seriously ill neonates. Different investigators have used ceftazidime alone or in combination with other agents in the successful treatment of infections in immuno\u2010suppressed patients. Adverse reactions have been few and are mostly reversible laboratory findings. The effects of ceftazidime on prothrombin synthesis and platelet function have been minimal, and no drug\u2010induced clinical bleeding has been reported.<\/jats:p>","DOI":"10.1002\/j.1875-9114.1985.tb03424.x","type":"journal-article","created":{"date-parts":[[2015,12,16]],"date-time":"2015-12-16T14:15:03Z","timestamp":1450275303000},"page":"254-267","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Antimicrobial Activity, Pharmacokinetics, Therapeutic Indications and Adverse Reactions of Ceftazidime"],"prefix":"10.1002","volume":"5","author":[{"given":"Layne O.","family":"Gentry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,1,24]]},"reference":[{"key":"e_1_2_1_1_2_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/1.1.4"},{"key":"e_1_2_1_1_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1978.03280420054018"},{"key":"e_1_2_1_1_4_2","first-page":"102","article-title":"Changing antibiotic susceptibility of common bacteria","volume":"11","author":"Williams JD.","year":"1977","journal-title":"Practitioner"},{"key":"e_1_2_1_1_5_2","first-page":"257","volume-title":"Medical microbiology and infectious diseases","author":"Neu HC.","year":"1981"},{"key":"e_1_2_1_1_6_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-97-3-408"},{"key":"e_1_2_1_1_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/8.suppl_B.233"},{"key":"e_1_2_1_1_8_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.me.32.020181.003015"},{"key":"e_1_2_1_1_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/12.2.119"},{"key":"e_1_2_1_1_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.18.1.195"},{"key":"e_1_2_1_1_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.16.5.533"},{"key":"e_1_2_1_1_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/6.suppl_A.25"},{"key":"e_1_2_1_1_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.23.3.435"},{"key":"e_1_2_1_1_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.25.4.534"},{"key":"e_1_2_1_1_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/6.suppl_A.19"},{"key":"e_1_2_1_1_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/8.suppl_B.5"},{"key":"e_1_2_1_1_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/8.suppl_B.15"},{"key":"e_1_2_1_1_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/8.suppl_B.23"},{"key":"e_1_2_1_1_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/8.suppl_B.33"},{"key":"e_1_2_1_1_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/8.suppl_B.53"},{"key":"e_1_2_1_1_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/8.suppl_B.57"},{"key":"e_1_2_1_1_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/8.suppl_B.63"},{"key":"e_1_2_1_1_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/8.suppl_B.73"},{"key":"e_1_2_1_1_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/8.suppl_B.79"},{"key":"e_1_2_1_1_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/8.suppl_B.83"},{"key":"e_1_2_1_1_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/8.suppl_B.91"},{"key":"e_1_2_1_1_27_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/8.suppl_B.97"},{"key":"e_1_2_1_1_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/8.suppl_B.111"},{"key":"e_1_2_1_1_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/8.suppl_B.119"},{"key":"e_1_2_1_1_30_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/8.suppl_B.131"},{"key":"e_1_2_1_1_31_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/8.suppl_B.163"},{"key":"e_1_2_1_1_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/8.suppl_B.169"},{"key":"e_1_2_1_1_33_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/8.suppl_B.175"},{"key":"e_1_2_1_1_34_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/8.suppl_B.187"},{"key":"e_1_2_1_1_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.21.1.11"},{"key":"e_1_2_1_1_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-2911(08)60376-8"},{"key":"e_1_2_1_1_37_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/8.suppl_B.141"},{"key":"e_1_2_1_1_38_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/8.suppl_B.147"},{"key":"e_1_2_1_1_39_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.20.5.567"},{"key":"e_1_2_1_1_40_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.26.3.388"},{"key":"e_1_2_1_1_41_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.20.3.356"},{"key":"e_1_2_1_1_42_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.22.2.237"},{"key":"e_1_2_1_1_43_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.23.6.892"},{"key":"e_1_2_1_1_44_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.24.2.141"},{"key":"e_1_2_1_1_45_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/10.3.199"},{"key":"e_1_2_1_1_46_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.25.2.201"},{"key":"e_1_2_1_1_47_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/8.suppl_B.263"},{"key":"e_1_2_1_1_48_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/8.suppl_B.273"},{"key":"e_1_2_1_1_49_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/8.suppl_B.277"},{"key":"e_1_2_1_1_50_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1980.96"},{"key":"e_1_2_1_1_51_2","first-page":"157","volume-title":"New beta\u2010lactam antibiotics: a review from chemistry to clinical efficacy of the new cephalosporins","author":"Luthy R.","year":"1982"},{"key":"e_1_2_1_1_52_2","first-page":"177","volume-title":"New beta\u2010lactam antibiotics: a review from chemistry to clinical efficacy of the new cephalosporins","author":"Coombes JD.","year":"1982"},{"key":"e_1_2_1_1_53_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/12.suppl_A.235"},{"issue":"4","key":"e_1_2_1_1_54_2","first-page":"174","article-title":"Evaluations of new drugs: mechanism of action, antimicrobical activity, pharmacology, adverse effects and clinical efficacy of cefotaxime","volume":"2","author":"LeFrock JL","year":"1982","journal-title":"Pharmacology"},{"key":"e_1_2_1_1_55_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/12.suppl_A.341"},{"key":"e_1_2_1_1_56_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.26.4.583"},{"key":"e_1_2_1_1_57_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1984.187"},{"key":"e_1_2_1_1_58_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/12.suppl_A.289"},{"key":"e_1_2_1_1_59_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/1.suppl_3.119"},{"key":"e_1_2_1_1_60_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/8.suppl_B.241"},{"key":"e_1_2_1_1_61_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/12.suppl_A.251"},{"key":"e_1_2_1_1_62_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/12.suppl_A.241"},{"key":"e_1_2_1_1_63_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/12.suppl_A.255"},{"key":"e_1_2_1_1_64_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/8.suppl_B.289"},{"key":"e_1_2_1_1_65_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/12.suppl_A.241"},{"key":"e_1_2_1_1_66_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/12.suppl_A.263"},{"key":"e_1_2_1_1_67_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/12.suppl_A.177"},{"key":"e_1_2_1_1_68_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/12.suppl_A.275"},{"key":"e_1_2_1_1_69_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.23.3.479"},{"key":"e_1_2_1_1_70_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/8.suppl_B.293-b"},{"key":"e_1_2_1_1_71_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.25.6.760"},{"key":"e_1_2_1_1_72_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/8.suppl_B.339"},{"key":"e_1_2_1_1_73_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/13.5.437"},{"key":"e_1_2_1_1_74_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/13.5.517"},{"key":"e_1_2_1_1_75_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.26.1.115"},{"key":"e_1_2_1_1_76_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/11.2.198"},{"key":"e_1_2_1_1_77_2","first-page":"47","article-title":"Ceftizoxime: A beta\u2010lactamase\u2010stable, broad\u2010spectrum cephalosporin","volume":"4","author":"Neu HC.","year":"1984","journal-title":"Pharmacology"},{"issue":"4","key":"e_1_2_1_1_78_2","first-page":"197","article-title":"A comparative evaluation of moxalactam: antimicrobial activity, pharmacokinetics, adverse reactions, and clinical efficacy","volume":"2","author":"Fitzpatrick BJ","year":"1982","journal-title":"Pharmacology"},{"key":"e_1_2_1_1_79_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/12.suppl_A.269"},{"key":"e_1_2_1_1_80_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/12.suppl_A.53"},{"key":"e_1_2_1_1_81_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/12.suppl_A.41"},{"key":"e_1_2_1_1_82_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/12.suppl_A.65"},{"key":"e_1_2_1_1_83_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/12.suppl_A.47"},{"key":"e_1_2_1_1_84_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/12.suppl_A.59"},{"key":"e_1_2_1_1_85_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/12.suppl_A.77"},{"key":"e_1_2_1_1_86_2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/archinte.1984.00350130063013","article-title":"Clinical efficacy of ceftazidime: treatment of serious infection due to multiresistant pseudomonas and other gram\u2010negative bacteria","volume":"144","author":"Scully BE","year":"1984","journal-title":"Arch Intern Med"},{"key":"e_1_2_1_1_87_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.25.3.395"},{"key":"e_1_2_1_1_88_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/12.suppl_A.21"},{"key":"e_1_2_1_1_89_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/12.suppl_A.31"},{"key":"e_1_2_1_1_90_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/12.suppl_A.123"},{"key":"e_1_2_1_1_91_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/12.suppl_A.9"},{"key":"e_1_2_1_1_92_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/12.suppl_A.27"},{"key":"e_1_2_1_1_93_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/12.suppl_A.101"},{"key":"e_1_2_1_1_94_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.23.2.236"},{"key":"e_1_2_1_1_95_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/12.suppl_A.171"},{"key":"e_1_2_1_1_96_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/12.suppl_A.283"},{"key":"e_1_2_1_1_97_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/12.suppl_A.289"},{"key":"e_1_2_1_1_98_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/12.suppl_A.297"},{"key":"e_1_2_1_1_99_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/12.suppl_A.313"},{"key":"e_1_2_1_1_100_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/12.suppl_A.325"},{"key":"e_1_2_1_1_101_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/12.suppl_A.331"},{"key":"e_1_2_1_1_102_2","unstructured":"BlumerJL SternRC ReedMD.Efficacy and safety of ceftazidime forPseudomonas cepaciainfections in cystic fibrosis (abstr 851). Presented at the Twenty\u2010fourth Interscience Conference on Antimicrobial Agents and Chemotherapy Washington DC October 1984."},{"issue":"2","key":"e_1_2_1_1_103_2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0002-9343(85)90264-5","article-title":"The use of ceftazidime for the treatment of skin, and skin structure, bone and joint infections","volume":"79","author":"Gentry LO.","year":"1984","journal-title":"Am J Med"},{"key":"e_1_2_1_1_104_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/12.suppl_A.229"},{"key":"e_1_2_1_1_105_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/12.suppl_A.383"},{"key":"e_1_2_1_1_106_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.24.4.500"},{"key":"e_1_2_1_1_107_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.26.3.318"},{"key":"e_1_2_1_1_108_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(85)90261-X"},{"key":"e_1_2_1_1_109_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/12.suppl_A.347"},{"key":"e_1_2_1_1_110_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/12.suppl_A.353"},{"key":"e_1_2_1_1_111_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/12.suppl_A.357"},{"key":"e_1_2_1_1_112_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/12.suppl_A.365"},{"key":"e_1_2_1_1_113_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/12.suppl_A.81"},{"key":"e_1_2_1_1_114_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/12.suppl_A.89"},{"key":"e_1_2_1_1_115_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/12.suppl_A.93"},{"key":"e_1_2_1_1_116_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/12.suppl_A.115"},{"key":"e_1_2_1_1_117_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/12.suppl_A.131"},{"key":"e_1_2_1_1_118_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/12.suppl_A.139"},{"key":"e_1_2_1_1_119_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/12.suppl_A.147"},{"key":"e_1_2_1_1_120_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/12.suppl_A.161"},{"key":"e_1_2_1_1_121_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/12.suppl_A.181"},{"key":"e_1_2_1_1_122_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/12.suppl_A.71"},{"key":"e_1_2_1_1_123_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(85)90268-2"},{"key":"e_1_2_1_1_124_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.24.3.333"},{"key":"e_1_2_1_1_125_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/8.suppl_B.345"},{"key":"e_1_2_1_2_1_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1982.00340200025004"},{"key":"e_1_2_1_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(85)90264-5"},{"key":"e_1_2_1_3_3_2","first-page":"3","article-title":"Use of ceftazidime in the management of bacterial cellulitis in infants and children","volume":"37","author":"Gooch III WM","year":"1985","journal-title":"Curr Ther Res"},{"key":"e_1_2_1_3_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.26.4.583"},{"key":"e_1_2_1_3_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(85)90261-X"},{"key":"e_1_2_1_3_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/148.5.892"}],"container-title":["Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fj.1875-9114.1985.tb03424.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fj.1875-9114.1985.tb03424.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/j.1875-9114.1985.tb03424.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:44:36Z","timestamp":1761043476000},"score":1,"resource":{"primary":{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/10.1002\/j.1875-9114.1985.tb03424.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,9,10]]},"references-count":130,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1985,9,10]]}},"alternative-id":["10.1002\/j.1875-9114.1985.tb03424.x"],"URL":"https:\/\/doi.org\/10.1002\/j.1875-9114.1985.tb03424.x","archive":["Portico"],"relation":{},"ISSN":["0277-0008","1875-9114"],"issn-type":[{"value":"0277-0008","type":"print"},{"value":"1875-9114","type":"electronic"}],"subject":[],"published":{"date-parts":[[1985,9,10]]},"assertion":[{"value":"2012-01-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}